{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:10:38Z","timestamp":1784704238830,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.amjcard.2025.08.041","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T23:14:35Z","timestamp":1756250075000},"page":"27-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Efficacy and Safety of Different Combinations of Add-on Diuretic Therapy in Acute Heart Failure: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1016","volume":"258","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9945-3549","authenticated-orcid":false,"given":"Andrew","family":"Sephien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia G","family":"Girgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tea","family":"Reljic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisse Camille","family":"Dayto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna M.","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason N.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Tallaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario A.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Tsalatsanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambuj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2025.08.041_bib0001","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cardfail.2023.07.006","article-title":"Writing Committee M. Heart Failure Epidemiology and Outcomes Statistics: a report of the Heart Failure Society of America","volume":"29","author":"Bozkurt","year":"2023","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2012.10.002","article-title":"Heart failure","volume":"1","author":"Braunwald","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0003","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2022.02.010","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure","volume":"28","year":"2022","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0004","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCHEARTFAILURE.111.963413","article-title":"Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function","volume":"5","author":"Metra","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0005","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/ehjci\/jeae075","article-title":"Poor in-hospital congestion improvement in acute heart failure patients classified according to left ventricular ejection fraction: prognostic implications","volume":"25","author":"Ruocco","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0006","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/HYPERTENSIONAHA.120.15205","article-title":"Pathophysiology of diuretic resistance and its implications for the management of chronic heart failure","volume":"76","author":"Wilcox","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0007","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/ehac530","article-title":"Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial","volume":"44","author":"Biegus","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0008","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in acute decompensated heart failure with volume overload","volume":"387","author":"Mullens","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0009","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/eurheartj\/ehad341","article-title":"Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics","volume":"44","author":"Yeoh","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0010","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0011","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ejhf.2384","article-title":"Worsening renal function in acute heart failure in the context of diuretic response","volume":"24","author":"Emmens","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0012","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0013","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"Cochrane Bias Methods G, Cochrane Statistical Methods G. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0014","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0016","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0017","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1002\/sim.8158","article-title":"Network meta-analysis of rare events using the Mantel-Haenszel method","volume":"38","author":"Efthimiou","year":"2019","journal-title":"Stat Med"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v106.i02","article-title":"An R package for network meta-analysis using frequentist methods","volume":"106","author":"Balduzzi","year":"2023","journal-title":"J Statistical Software"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0019","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ihj.2014.03.006","article-title":"A prospective, randomized study to evaluate the efficacy of various diuretic strategies in acute decompensated heart failure","volume":"66","author":"Shah","year":"2014","journal-title":"Indian Heart J"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(19)32734-2","article-title":"High-dose spironolactone in High risk acute decompensated heart failure: randomized clinical trial","volume":"73","author":"Apriansyah","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0021","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","article-title":"Blood Institute Heart Failure Clinical Research N. Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial","volume":"2","author":"Butler","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0022","doi-asserted-by":"crossref","first-page":"11","DOI":"10.18087\/cardio.2023.8.n2221","article-title":"The use of Dapagliflozin in acute decompensated heart failure: results of the randomized study","volume":"63","author":"Charaya","year":"2023","journal-title":"Kardiologiia"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0023","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/jama.2013.282190","article-title":"Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial","volume":"310","author":"Chen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0024","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jacc.2024.02.009","article-title":"Efficacy and safety of Dapagliflozin in patients with acute heart failure","volume":"83","author":"Cox","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0025","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/ejhf.1713","article-title":"Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF)","volume":"22","author":"Damman","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176179","article-title":"The clinical outcomes of dapagliflozin in patients with acute heart failure: a randomized controlled trial (DAPA-RESPONSE-AHF)","volume":"961","author":"Emara","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0027","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2016.09.004","article-title":"Efficacy and safety of Tolvaptan in patients hospitalized with acute heart failure","volume":"69","author":"Felker","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0028","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Acute, chronic therapeutic impact of a vasopressin antagonist in congestive heart failure I. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial","volume":"291","author":"Gheorghiade","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0029","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s40261-017-0577-1","article-title":"Acetazolamide as add-on diuretic therapy in exacerbations of chronic heart failure: a pilot study","volume":"37","author":"Imiela","year":"2017","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0030","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.jacc.2016.12.035","article-title":"Secret of Chf Investigators C, Committee M. Short-term effects of Tolvaptan in patients with acute heart failure and volume overload","volume":"69","author":"Konstam","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0031","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Efficacy of Vasopressin antagonism in heart failure outcome study with Tolvaptan I. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0032","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cardfail.2016.02.007","article-title":"Clinical effectiveness of Tolvaptan in patients with acute heart failure and renal dysfunction","volume":"22","author":"Matsue","year":"2016","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0033","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.122.062486","article-title":"Decongestion with acetazolamide in acute decompensated heart failure across the spectrum of left ventricular ejection fraction: a prespecified analysis from the ADVOR trial","volume":"147","author":"Martens","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0034","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/ejhf.2863","article-title":"Sodium and potassium changes during decongestion with acetazolamide - A pre-specified analysis from the ADVOR trial","volume":"25","author":"Dhont","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0035","article-title":"Effect of adding hydrochlorothiazide to usual treatment of patients with acute decompensated heart failure: a randomized clinical trial","volume":"11","author":"Piardi","year":"2021","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"10.1016\/j.amjcard.2025.08.041_bib0036","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ihj.2015.07.006","article-title":"Effect of tolvaptan on acute heart failure with hyponatremia\u2013a randomized, double blind, controlled clinical trial","volume":"68","author":"Shanmugam","year":"2016","journal-title":"Indian Heart J"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0037","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1253\/circj.CJ-16-1122","article-title":"Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure and preserved left ventricular ejection fraction- prospective randomized controlled study","volume":"81","author":"Tamaki","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0038","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.122.059038","article-title":"Effects of early Empagliflozin initiation on Diuresis and kidney function in patients with acute decompensated heart failure (EMPAG-HF)","volume":"146","author":"Schulze","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0039","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijcard.2013.12.276","article-title":"Efficacy and safety of high dose versus low dose furosemide with or without dopamine infusion: the dopamine in acute decompensated heart failure II (DAD-HF II) trial","volume":"172","author":"Triposkiadis","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0040","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/eurheartj\/ehac689","article-title":"Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial","volume":"44","author":"Trulls","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0041","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cardfail.2011.08.005","article-title":"A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction","volume":"17","author":"Udelson","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0042","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0043","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jchf.2018.04.008","article-title":"Osler Medical H. Randomized evaluation of heart failure with preserved ejection fraction patients with acute heart failure and dopamine: the ROPA-DOP trial","volume":"6","author":"Sharma","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0044","unstructured":"Chitthai R, Saisa-ard J, Inkong P, Chaiprasert A, Nata N, Tasanavipas P, Varothai N, Thimachai P, Supasyndh O, & Satirapoj B. Benefit of add on low dose oral tolvaptan to loop diuretics among patients with acute decompensated heart failure: a randomized controlled trial. Journal of the Nephrology Society of Thailand, 2022;28(2):50\u201359. retrieved from https:\/\/he01.tci-thaijo.org\/index.php\/JNST\/article\/view\/258804."},{"key":"10.1016\/j.amjcard.2025.08.041_bib0045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.20996\/1819-6446-2023-03-02","article-title":"Clinical efficacy and safety of Empagliflozin in patients with acute heart failure from the first day of hospitalization","volume":"19","author":"Golubovskaya","year":"2023","journal-title":"Ration Pharmacother Cardiol"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0046","unstructured":"Pratyarattananon , P. . ., Pratyarattana, P. . non ., & Chitinandana , A. . . (2022). Tolvaptan Plus Low-Dose Furosemide Compared with Titraing Furosemide in Acute Decompensated Heart Failure Patients Who Does Not Response to Initial Furosemide Dose. Royal Thai Air Force Medical Gazette, 67(2), 29\u201343. retrieved from https:\/\/he02.tci-thaijo.org\/index.php\/rtafmg\/article\/view\/260142"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0047","article-title":"Diuretic, natriuretic, and chloride-regaining effects of oral acetazolamide as an add-on therapy for acute heart failure with volume overload: a single-center, prospective, randomized study","volume":"133","author":"Kosiorek","year":"2023","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0048","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40256-024-00633-9","article-title":"Acetazolamide as an adjunctive diuretic therapy for patients with acute decompensated heart failure: a systematic review and meta-analysis","volume":"24","author":"Siddiqi","year":"2024","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0049","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.614","article-title":"Tolvaptan add-on therapy in patients with acute heart failure: a systematic review and meta-analysis","volume":"8","author":"Luo","year":"2020","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.amjcard.2025.08.041_bib0050","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914925005053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914925005053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T01:29:49Z","timestamp":1765070989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914925005053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":50,"alternative-id":["S0002914925005053"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.08.041","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Different Combinations of Add-on Diuretic Therapy in Acute Heart Failure: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.08.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}